Zymeworks to present at three major investor conferences in May and June 2026

Zymeworks Inc., a biotechnology company, announced its management will participate in three upcoming investor conferences: the Stifel Virtual Targeted Oncology Forum on May 20, the TD Cowen Oncology Innovation Summit on May 27, and the Jefferies Global Healthcare Conference on June 3. These events will feature one-on-one meetings and fireside chats, providing opportunities to discuss Zymeworks' pipeline of novel biotherapeutics and licensed healthcare assets. This participation highlights Zymeworks' ongoing efforts to engage investors and showcase its advancements in cancer and autoimmune disease treatments.